Sunday, November 22, 2026Every story links to its original source.

Genome News

Genomics news, traced to the source.

Reading

studyarchive2 min read

Newborn screening found 2 confirmed diagnoses among 27 initial biochemical positives

Illustrative photo by Vicki Yde, Pexels LicenseImage licenceFull-size image

Biochemical newborn screening produced 27 initial positive results in a Chinese study, of which 2 became confirmed diagnoses. That gave the initial screen a positive predictive value of 7.4%, meaning the share of positive results confirmed as cases. The Scientific Reports study enrolled 6204 newborns at Jinan Maternity and Child Care Hospital between May 2023 and June 2026. Genetic screening identified 2 confirmed cases, while combined biochemical and genetic screening identified 1. The authors reported that genetic screening was better at distinguishing newborns without the disorders, but required enzyme testing before its results could guide clinical decisions.

Parents chose the screening approach for their newborns: 2581 received biochemical screening alone, 3193 received genetic screening alone, and 430 received both. Allocation reflected parental preference.

Of the 27 initial biochemical positives, 5 remained positive on repeat testing. The 2 confirmed diagnoses were 1 Fabry disease and 1 Krabbe disease. Genetic screening also identified 1 Fabry and 1 Krabbe case. Combined screening identified 1 Fabry case. These are lysosomal storage disorders, a group of severe inherited metabolic diseases for which early diagnosis enables timely disease specific treatment and improves long term outcomes.

The authors described biochemical screening as having high sensitivity, meaning it was good at detecting affected newborns. Its low specificity meant it also returned positive results without a confirmed diagnosis. Genetic screening had higher specificity. The authors concluded that combining the approaches provided high diagnostic accuracy and reduced false positive recalls, when families return for further testing after a positive screen. The abstract reports no false positive recall figures for the combined group.

The study reported a carrier frequency of 3.78%, defined as carrying at least one DNA variant classified as disease-causing or likely disease-causing. GALC c.1901T>C, GALC c.2041G>A and GAA c.761C>T accounted for 68.6% of all carriers. Comparison with ExAC-EAS, an East Asian genetic reference dataset, found that GALC c.2041G>A was more common in the northern Chinese population. The researchers suggested a regional founder effect, in which a variant becomes more common through inheritance from a shared ancestor.

The carrier findings provide reference data for designing lysosomal storage disorder screening programs in Chinese populations. GALC c.1901T>C had a reported frequency of 1.71%, followed by GALC c.2041G>A at 0.69% and GAA c.761C>T at 0.19%.

Written by the Genomes desk from the primary source cited and linked above and checked against it. Research use only; not medical advice. Corrections: [email protected].

More from the archive

Back to the latest · Archive